Developers believe the study is the first-in-human demonstration for a drug that could safely prevent its development.

A new preclinical study has demonstrated that combining HER3-DXd with olaparib significantly improves treatment responses in ...

Cancer immunotherapy has reshaped the oncology landscape over the past decade, but the next phase of development is ...

Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer ...

Chennai, Aug. 28 -- Highlights: ...

Chemotherapy remains what many people picture when they hear a cancer diagnosis, but treatment for certain blood cancers now ...

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable. Dr. Augusto Villanueva Rodriguez, medical director of the Liver ...

Medical professionals at Charité – Universitätsmedizin Berlin have successfully utilized CAR T-cell therapy, originally ...

Researchers discovered a possible way cancer cells hide from the immune system: they build a thick, sugar-rich coating around ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to ...

New treatments are being explored for glioblastoma and ovarian cancer, incurable and difficult-to-treat cancers.